Literature DB >> 28031505

Z-plasty of the flexor hallucis longus tendon at tarsal tunnel for checkrein deformity.

Jae Hoon Lee1, Young Jun Kim2, Jong Hun Baek2, Dong Hee Kim2.   

Abstract

PURPOSES: To review the outcome of Z-plasty of the flexor hallucis longus (FHL) tendon at the tarsal tunnel for checkrein deformity in 8 patients.
METHODS: Records of 6 males and 2 females aged 14 to 67 (mean, 39.5) years who underwent Z-plasty (lengthening) of the FHL tendon at the tarsal tunnel for checkrein deformity in the first and second toes by a single surgeon were reviewed. All patients had undergone 3 months of conservative treatment. The mean time from injury to surgical treatment was 8.4 (range, 5-12) months. All patients had associated injuries including distal tibiofibular fracture (n=6), distal fibular fracture (n=1), and crush injury aroundthe ankle (n=1); they were treated with intramedullary nailing (n=6), long leg splinting (n=1), and short leg splinting (n=1).
RESULTS: After a mean follow-up of 3.4 (range, 1-7) years, the FHL tendon was lengthened by a mean of 1.7 (range, 1.6-1.8) cm, and the mean American Orthopedic Foot and Ankle Society hallux score increased from 59 (range, 52-67) to 89 (range, 80-90). No patient had recurrence, nerve injury, or tarsal tunnel syndrome, although one patient had sensory disturbance of the posterior tibial nerve in the forefoot, which resolved spontaneously at week 2.
CONCLUSION: Z-plasty of the FHL tendon at the tarsal tunnel is a viable option for correction of checkrein deformity.

Entities:  

Keywords:  foot deformities, acquired; tendons

Mesh:

Year:  2016        PMID: 28031505     DOI: 10.1177/1602400316

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  1 in total

Review 1.  Retro-Malleolar Z-Plasty of Flexor Hallucis Longus Tendon in Post-Traumatic Checkrein Deformity: A Case Series and Literature Review.

Authors:  Chiara Polichetti; Tommaso Greco; Michele Inverso; Giulio Maccauro; Fabrizio Forconi; Carlo Perisano
Journal:  Medicina (Kaunas)       Date:  2022-08-10       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.